The Parkinson Progression Marker Initiative (PPMI)Kenneth Marek, Marne Baca, Danna Jennings et al.|Progress in Neurobiology|2011Cited by 1.9k
AFQ056 in Parkinson patients with levodopa‐induced dyskinesia: 13‐week, randomized, dose‐finding studyFabrizio Stocchi, Claudia Trenkwalder, Olivier Rascol et al.|Movement Disorders|2013Cited by 137
A Randomized Phase 3 Study Comparing <scp>P2B001</scp> to its Components (Low‐Dose Extended‐Release Rasagiline and Pramipexole) and to Optimized Doses of Marketed Extended‐Release Pramipexole in Early Parkinson's DiseaseC. Warren Olanow, Ramon Gil, David Kreitzman et al.|Movement Disorders|2023Cited by 5